During the past decade, Aultman Medical Group Hematology and Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aultman Medical Group Hematology and Oncology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Aultman Medical Group Hematology and Oncology" are "Metastatic Breast Cancer" (1 trials), "Thyroid Dysfunction" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Aultman Medical Group Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "Aultman Medical Group Hematology and Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Placebo" (1 trials) and "Triiodothyronine (T3)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aultman Medical Group Hematology and Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Aultman Medical Group Hematology and Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Aultman Medical Group Hematology and Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aultman Medical Group Hematology and Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Aultman Medical Group Hematology and Oncology has several departments that took part in Clinical trials: "Alliance Cancer Center" - 2 trials